Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 8.92% vs 10.35% in Sep 2024
Standalone Net Profit
YoY Growth in quarter ended Sep 2025 is 16.65% vs 29.07% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 12.05% vs 26.37% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -5.03% vs 87.06% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Indrapr.Medical With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 4.37% vs 9.38% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 8.92% vs 10.35% in Sep 2024
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2025 is -3.89% vs 25.48% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 16.65% vs 29.07% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -2.52% vs 19.29% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 12.05% vs 26.37% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -3.21% vs 4.70% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -5.03% vs 87.06% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






